CROWELL GAYLE A — SEC Form 4 filings
SEC reporting owner CIK 1250893. 12 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-03-04 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 6 filings — 32,408 shares, $535,548 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: purchase of 6,000 shares @ $17.77 ($106,647) in Hercules Capital, Inc., filed 2025-11-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Hercules Capital, Inc. (HTGC) | Director | 7 | 6 legs · 32,408 sh · $535,548 | — | 1 |
| ENVESTNET, INC. (ENV) | Director | 2 | — | — | 4 |
| PLIANT THERAPEUTICS, INC. (PLRX) | Director | 3 | — | — | 3 |
Form 4 filings — CROWELL GAYLE A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2026-03-30 | 4 | Hercules Capital, Inc. (HTGC) | Purchase (P): 7,317 @ $14.35 | EDGAR |
| 2026-02-25 | 4 | Hercules Capital, Inc. (HTGC) | Purchase (P): 6,600 @ $15.20 | EDGAR |
| 2025-11-04 | 4 | Hercules Capital, Inc. (HTGC) | Purchase (P): 6,000 @ $17.77 | EDGAR |
| 2025-06-09 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-05-09 | 4 | Hercules Capital, Inc. (HTGC) | Purchase (P): 5,999 @ $17.49 | EDGAR |
| 2024-11-25 | 4 | ENVESTNET, INC. (ENV) | Disposition to issuer (D): 17,075 @ $63.15 · Disposition to issuer (D): 3,852 @ $63.15 · Disposition to issuer (D): 1,745 (derivative) | EDGAR |
| 2024-08-08 | 4 | Hercules Capital, Inc. (HTGC) | Purchase (P): 5,790 @ $18.06 | EDGAR |
| 2024-06-26 | 4 | Hercules Capital, Inc. (HTGC) | Purchase (P): 701.60 @ $20.05 | EDGAR |
| 2024-06-24 | 4 | Hercules Capital, Inc. (HTGC) | Grant/award (A): 3,030 @ $19.80 | EDGAR |
| 2024-06-17 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/award (A): 26,764 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | ENVESTNET, INC. (ENV) | Grant/award (A): 3,987 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1250893 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →